Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

NCT03316404 is registered in ClinicalTrials.gov with DxTerity Diagnostics as lead sponsor.

NCT NCT03316404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03316404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
Lead sponsor
DxTerity Diagnostics
Phase
Observational
Overall status
Completed
Start date
November 7, 2017
Completion date
February 25, 2020
Enrollment
1,168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ms, multiple sclerosis